BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA AND Treatment
13 results:

  • 1. ciita-Transduced Glioblastoma cells Uncover a Rich Repertoire of Clinically Relevant tumor-Associated HLA-II Antigens.
    Forlani G; Michaux J; Pak H; Huber F; Marie Joseph EL; Ramia E; Stevenson BJ; Linnebacher M; Accolla RS; Bassani-Sternberg M
    Mol Cell Proteomics; 2021; 20():100032. PubMed ID: 33592498
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
    Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
    FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.
    Zhao D; Amria S; Hossain A; Sundaram K; Komlosi P; Nagarkatti M; Haque A
    Cell Immunol; 2011; 271(2):392-400. PubMed ID: 21903207
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
    Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the ciita gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epigenetic silencing of the ciita gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but ciita-independent.
    O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS
    J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Class II transactivator (ciita) promoter methylation does not correlate with silencing of ciita transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lack of IFN-gamma-mediated induction of the class II transactivator (ciita) through promoter methylation is predominantly found in developmental tumor cell lines.
    van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
    Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy.
    Burton JL; Lidbury EA; Gillespie AM; Tidy JA; Smith O; Lawry J; Hancock BW; Wells M
    Histopathology; 2001 May; 38(5):409-17. PubMed ID: 11422477
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
    Morris AC; Spangler WE; Boss JM
    J Immunol; 2000 Apr; 164(8):4143-9. PubMed ID: 10754309
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.